'Accordingly, we believe that the time has come to recommend AVR for asymptomatic patients with severe AS. This paradigm shift is anticipated to yield improved patient outcomes, public health, and resource utilization. It is time to act.'
'Accordingly, we believe that the time has come to recommend AVR for asymptomatic patients with severe AS. This paradigm shift is anticipated to yield improved patient outcomes, public health, and resource utilization. It is time to act.'
Journal of the Heart Valve Society - Volume 1, Number 1, Oct 01, 2024
Podcasts on the articles published:
sageclinical.libsyn.com/webpage/size...
Journal of the Heart Valve Society - Volume 1, Number 1, Oct 01, 2024
Podcasts on the articles published:
sageclinical.libsyn.com/webpage/size...